Academy Exchange

Expand all | Collapse all

Clinical Research Update 7/28/2020 - DTG/3TC Efficacy

  • 1.  Clinical Research Update 7/28/2020 - DTG/3TC Efficacy

    Posted 8 days ago

    In this week's Clinical Research Update, I highlight three studies that all support efficacy of DTG/3TC as an appropriate regimen for patients with HIV. For those of us who have been treating patients with HIV since the days of AZT monotherapy and then dual nucleoside therapy (which ultimately failed), it remains cognitively challenging to use only two drugs to treat patients. However, the data are increasingly compelling and we will soon have IM cabotegravir/rilpivirine as another dual therapy option.

     

    You can find the full summary, and all the archived Clinical Research Updates, on the Academy's website.



    ------------------------------
    Jeffrey Kirchner
    Lancaster General Health Physicians (LGHP) - Comprehensive Care
    Lancaster PA
    ------------------------------


  • 2.  RE: Clinical Research Update 7/28/2020 - DTG/3TC Efficacy

    Posted 4 days ago
    I still sitting on the fence on this. I was a definite no on Juluca because of Rilpivirine.

    ------------------------------
    Tagbo Ekwonu
    Eastowne Family Physicians,PA
    Charlotte NC
    ------------------------------